Skip to main content

New Products

  • PhRMA: More than 260 medicines in development to treat skin diseases

    WASHINGTON — More than 200 drugs are under development in the United States for treating skin diseases, according to the country’s largest pharmaceutical industry trade group.

    The Pharmaceutical Research and Manufacturers of America said Monday that the country’s drug makers were developing 263 medicines for skin diseases that affect more than one-third of the U.S population. A study by the Lewin Group found that the annual total cost of skin diseases was $39.3 billion in 2005.

  • Lindt reaches for 'excellence' with new chocolate bars

    STRATHAM, N.H. — Lindt is expanding its dark chocolate offerings with two new Excellence bars.

    The Excellence 70% cocoa almond brittle balances the sweet crunch of almond brittle with dark chocolate, while the Excellence 70% cocoa nut crunch combines the subtle flavor and delicate crunch of of caramelized walnut and hazelnut pieces with dark chocolate. Each bar provides a "delightful dark chocolate experience," Lindt said.

  • Lemonade beverages join Trop50's lineup

    CHICAGO — Tropicana is giving its Trop50 brand a refreshing boost.

    Just in time for summer, Trop50 has debuted lemonade and raspberry lemonade beverages. Each variety contains no artificial sweeteners and 50% less sugar and calories.

    To celebrate the launch, Trop50 lemonade and raspberry lemonade will be supported in the brand's "Girlfriends" advertising campaign, which launched last September and features actress Jane Krakowski.

    Trop50's lineup also includes original Trop50 orange juice and farmstand apple juice.

  • Forest announces availability of Daliresp

    NEW YORK — A drug for chronic obstructive pulmonary disease made by Forest Labs will be available by the middle of this month, Forest said Thursday.

    Daliresp (roflumilast) recently received approval from the Food and Drug Administration as a treatment to reduce the risk of exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.

    Forest said Daliresp, a daily oral tablet, is the first and only approved drug in its class, known as selective phosphodiesterase-4 inhibitors.

  • HairMax LaserComb Lux 9 OKed to treat female pattern hair loss

    NEW YORK — Lexington has received clearance from the Food and Drug Administration for marketing the HairMax LaserComb Lux 9 to treat female pattern hair loss, the manufacturer has announced.

  • Nexcare teams up with American Red Cross, Niki Taylor for annual Nexcare Give program

    ST. PAUL, Minn. — 3M’s Nexcare bandages, in partnership with the American Red Cross and model Niki Taylor, on Thursday announced the third annual Nexcare Give program on World Blood Donor Day on June 14.

  • Clorox pushes Ingredients Inside program with upcoming mobile app, website

    OAKLAND, Calif. — In an effort to provide consumers with on-the-go access to product ingredient information, Clorox is slated to debut a new mobile app and website.

    Plans for the mobile app and website were previewed at the Sustainable Fragrances conference in Washington, D.C., on Thursday, where the company further emphasized its commitment to product ingredient transparency via its Ingredients Inside program.

  • Crio Brü seeks to deliver brewed cocoa drink

    OREM, Utah — A new brewed drink is looking to provide an alternative to coffee.

    Crio Brü, which contains 100% pure, premium cocoa beans, brews just like coffee, according to the company. Currently sold in coffee shops and coffee aisles at retail in Utah, as well as online, Crio Brü is available in Cavalla, Vega Real and Coca River flavors.

X
This ad will auto-close in 10 seconds